In this study, we evaluated the expression status of Gal9 and its associated biological processes and prognosis by analyzing RNA‐seq data and clinical data from two databases, with the hope of obtaining a comprehensive understanding of Gal9 and new findings in its use for the treatment of GBM. Here, LGALS9 is linked to glioblastoma.